Clinical trial Recruiting at 5 sites Interventional Ages 22 to 65

Evaluating a new implant system for knee cartilage degeneration

Official title: Evaluation of the Patellar LIFT System for Subjects With Patellofemoral Cartilage Degeneration

Run by ZKR Orthopedics Inc · NCT06423300 · Data updated 2026-11-12

This study is testing a new knee implant to see if it can help people with cartilage damage feel less pain and move better compared to a standard surgery.

Quick facts

Study typeInterventional
Ages22 Years to 65 Years
SexAll
Enrollment245 (estimated)
SponsorZKR Orthopedics Inc
Industry-sponsored
Locations5 sites (La Mesa, California and 4 other locations)
StatusRecruiting
StartedJune 19, 2024
Main results expectedSeptember 2027
Study endsSeptember 2031
Registry record updatedDecember 11, 2025
Trial IDNCT06423300 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 22 to 65 with significant anterior knee pain due to patellofemoral cartilage degeneration.

Probably not a fit

Patients with less severe cartilage degeneration or significant issues in the opposite knee may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial compares the outcomes of patients with patellofemoral cartilage degeneration treated with the LIFT Implant System against those undergoing Tibial Tubercle Osteotomy (TTO). It is a prospective, non-randomized, dual-arm, multi-center study designed to assess the effectiveness of the LIFT Implant in alleviating knee pain and improving function. Participants will be monitored for clinical outcomes over a specified period to determine the advantages of the LIFT system over traditional surgical methods.

Why it matters

Potential benefit: If successful, this study could provide a less invasive treatment option for patients suffering from knee pain due to cartilage degeneration.

How similar studies have gone: Other studies have shown promising results with similar approaches, but the LIFT Implant System is a novel intervention in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients age 22 to 65 years at time of screening
2. Anterior knee pain due to patellofemoral cartilage degeneration (PCD) with an Modified Outerbridge score of ≥3 as assessed by an MRI on the study knee
3. Body Mass Index (BMI) of ≤ 35
4. Weight \< 300 lbs
5. Anterior Knee Pain Score (AKPS) of ≤ 70 (0-100 scale)
6. Visual Analog Score (VAS) of ≥ 40 (0-100 scale)
7. Failure of at least 6 months of non-surgical treatment defined as at least one of the treatments (e.g. rest, bracing, physical therapy, targeted exercise, use of NSAIDs, activity level reduction or Confidential ZKR Orthopedics, CIP 0001 Page 11 of 55 Protocol Version: 1.0, 04JAN2024 modification, etc.) per AAOS Treatment of Osteoarthritis of the Knee; Evidence based guideline 3rd Edition 2021

Exclusion Criteria:

1. PCD with an Modified Outerbridge Score of 2 or less at the study knee
2. Clinical symptoms of the contralateral knee that preclude activities of daily living, stair climbing, stair descending, or require the use of an assist device
3. History of patella dislocation or instability
4. Patella alta or patella baja
5. Known TT-TG distance \>20mm
6. Patients requiring simultaneous cartilage grafting procedure, cartilage transplantation, or bone marrow stimulation
7. Previous repair of a torn patellar tendon
8. Prior TTO procedure or knee joint replacement (total or partial) of the study knee
9. Joint modifying surgery (e.g., ligament reconstruction, meniscus repair, cartilage transplantation, microfracture, etc.) in the study knee within 6 months prior to planned index procedure date
10. Arthroscopic surgeries in the study knee for joint lavage, meniscectomy, chondral debridement, and loose body removal within 3 months prior to planned index procedure
11. Active infection, sepsis, osteomyelitis or history of septic arthritis in any joint
12. Rheumatoid arthritis, other forms of inflammatory joint disease or autoimmune disorder
13. History of avascular necrosis of any bone
14. History of symptomatic patellar tendonitis of intrasubstance tear
15. Insufficiency of the cruciate, collateral ligaments, or tendon which would preclude stability of the LIFT System
16. Pathologic ligamentous injury (Lachman \> 1) or meniscus tearing
17. Clinical symptoms of the femoral-tibial joint of the study knee that preclude activities of daily living, stair climbing, stair descending, or requires the use of an assist device
18. Evidence (MRI, arthroscopy, etc.) of Modified Outerbridge Grade 4 degenerative arthritis in the femoral-tibial joint of the study knee that potentially explains patient symptoms

Where it's running

  • Horizon Clinical Research
    La Mesa, California, United States
    Recruiting
  • Hospital for Special Surgery
    New York, New York, United States
    Recruiting
  • NYU Langone Health
    New York, New York, United States
    Recruiting
  • Ohio State University - Jameson Crane Sports Medicine Institute
    Columbus, Ohio, United States
    Recruiting
  • Oregon Health and Science University
    Portland, Oregon, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • FDG PET/MRI to Find Painful Inflammation in the Patellofemoral Joint

    This study tests whether FDG PET/MRI can locate inflammation causing knee pain in people with patellofemoral joint osteoarthritis.

    Recruiting University of California, San Francisco · San Francisco, California · NCT07625150

  • Engineered cartilage grafts for treating knee osteoarthritis

    This study is testing a new cartilage treatment made from nasal cells to see if it helps people with knee osteoarthritis feel better compared to standard care options.

    Recruiting at 7 sites Phase 2 University Hospital, Basel, Switzerland · Vienna and 10 other locations · NCT06576583

  • Treatment for knee osteoarthritis using engineered cartilage from nasal cells

    This study is testing whether a new cartilage treatment made from nasal cells can help people with knee osteoarthritis feel less pain and improve their knee function compared to standard injections.

    Recruiting at 7 sites Phase 2 University Hospital, Basel, Switzerland · Zagreb and 8 other locations · NCT06163573

  • Comparing PRP and HA injections for knee osteoarthritis

    This study is testing whether injections of platelet-rich plasma or hyaluronic acid can help people with knee osteoarthritis feel better over two years.

    Recruiting Istituto Ortopedico Rizzoli · Bologna · NCT04937998

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.